Comments*

 
  • Neuroscience

  • Featured Event

    Green Buildings and Health: From the Lab to the Real World

    Wednesday, December 14, 2016 | 6:00 PM - 8:30 PM
    The New York Academy of Sciences

    Researchers at Harvard T.H. Chan School of Public Health and SUNY Upstate Medical University present the results of a new study showing that employees in high-performing, green-certified buildings had higher cognitive function test scores than those in similarly high-performing buildings that were not green certified, even after controlling for other potential explanatory factors.

  • Events 

    June 13 - 14, 2017

    Neuroplasticity, Neuroregeneration, and Brain Repair

    Keynote Speaker: Michael V. Sofroniew (David Geffen School of Medicine at UCLA)

    The conference will explore neuroregenerative processes and identify strategies for translating knowledge into treatments for neurodegenerative diseases and nervous system injuries.

    Thursday, November 2, 2017 | 9:00 AM - 5:00 PM

    Mitochondria in Health and Disease

    Speakers: Marcia Haigis (Harvard Medical School), Vamsi Mootha (Harvard Medical School), Andrew Dillin (UC Berkeley), Adam Hughes (University of Utah School of Medicine), Jahar Bhattacharya (Columbia University Irving Medical Center), Jodi Nunnari (University of California, Davis), Navdeep S. Chandel (Northwestern University), J. Wade Harper (Harvard Medical School), and David J. Glass (Novartis Institutes for Biomedical Research)

    This symposium will bring together cross-disciplinary researchers to explore mitochondrial biology, the role played by mitochondria in disease, and their potential as a therapeutic target.

  • Past Events

    Wednesday, May 24, 2017 | 12:00 PM - 5:00 PM

    Chemical Biology Discussion Group Year-End Symposium

    Speakers: Sean F. Brady (The Rockefeller University), Dirk Trauner (New York University)

    The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. In 2017, the annual year-end meeting features keynote speakers Dr. Sean F. Brady and Dr. Dirk Trauner.

    May 15 - 17, 2017

    13th International Conference on Myasthenia Gravis and Related Disorders

    Keynote Speaker: Vijay K. Kuchroo (Harvard Institutes of Medicine)

    Learn about most recent advances in basic, translational, and clinical research on the rare, acquired disorder, Myasthenia Gravis, as well as implications of this research on a range of related autoimmune and neuromuscular diseases.

    Tuesday, April 11, 2017 | 9:00 AM - 5:00 PM

    Gene Therapy for Rare Diseases

    Speakers: Brian Kaspar (AveXis Inc.), R. Jude Samulski (Bamboo Therapeutics), Barry Byrne (University of Florida Powell Gene Therapy Center), Maria Escolar (University of Pittsburgh), Jakub Tolar (University of Minnesota), Kevin Flanigan (Nationwide Children's Hospital), Katherine A. High (Spark Therapeutics), and Steven J. Gray (University of North Carolina at Chapel Hill)

    Gene therapy has been proposed as a promising therapeutic strategy for monogenic disorders. This symposium will explore recent advances in the field, and identify ongoing obstacles on the path to wider use of this approach.

    Tuesday, March 21, 2017 | 12:00 PM - 5:00 PM

    Exosomes in the CNS

    Speakers: Tsuneya Ikezu (Boston University School of Medicine), David Issadore (University of Pennsylvania), Xandra Breakefield (Massachusetts General Hospital), Efrat Levy (NYU School of Medicine), Robert A. Rissman (University of California San Diego, School of Medicine), and Andrew West (The University of Alabama at Birmingham)

    In this symposium we will explore the contribution of extracellular vesicles to pathological processes underlying neurodegenerative disorders, and the appeal of exosomes as biomarkers and targets for the development of novel therapeutics.

  • Publications 

    eBriefing

    Alzheimer's Disease as a Neurovascular Inflammatory Disorder

    Keynote Speaker: Costantino Iadecola (Weill Cornell Medicine)

    This eBriefing covers the basic research and clinical science elucidating such mechanisms that underlie the contribution of inflammatory pathways to vascular cognitive impairment and dementia.

    eBriefing

    Multiple Sclerosis: Diagnostic and Treatment Frontiers

    Keynote Speakers: Barry G. Arnason, MD (University of Chicago) and Giancarlo Comi, MD (Università Vita-Salute San Raffaele)

    This one-day, translational conference brought together academic and clinical researchers with industry leaders to discuss current therapeutics.

    eBriefing

    MicroRNAs: A Gene Silencing Mechanism with Therapeutic Implications

    Keynote Speaker: David Bartel (Whitehead Institute for Biomedical Research, Howard Hughes Medical Institute, MIT)

    MicroRNAs (miRNA) play critical roles in regulating gene expression. This symposium presented up-to-date basic, translational, and clinical research addressing the biology of miRNA and their promise as a therapeutic target.

    Annals

    Special Issue: Annals Reports

    Edited by Annals of the New York Academy of Sciences editorial staff.

    This diverse collection of papers discusses topics ranging from a paleobiologic study of the emergence of the diaphragm to changes in gait patterns after acute brain injury.